Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (fra:FDY) Share Price

Company Profile

Business description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
Contact
308 Cailun Road
Zhangjiang Hi-Tech Park
Pudong
Shanghai201210
CHN
T: +86 2158953355
http://www.fd-zj.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
899

Recommended

Investors cheered an increased dividend but still heavily dependent on iron ore.

Jon Mills, CFA | 18 February 2026

Our view of the shares after investors cheer results.

Jon Mills, CFA | 17 February 2026

We maintain our fair value as talks continue with Paramount,

Matthew Dolgin, CFA | 17 February 2026

Index	Last price	Change	% Change
All Ordinaries	9,238.70	21.50	0.23%
CAC 40	8,361.46	44.96	0.54%
DAX 40	24,998.40	197.49	0.80%
Dow JONES (US)	49,529.43	28.50	0.06%
FTSE 100	10,556.17	82.48	0.79%
HKSE	26,705.94	138.82	0.52%
NASDAQ	22,557.17	10.50	0.05%
Nikkei 225	57,283.06	716.57	1.27%
NZX 50 Index	13,247.02	129.11	0.98%
S&P 500	6,839.81	3.64	0.05%
S&P/ASX 200	9,007.00	12.80	0.14%
SSE Composite Index	4,082.07	51.95	-1.26%